of the female reproductive system [4] . Epithelial ovarian Between 1975 and 1990, 79 patients with Stage I epithelial ovar-tumors account for 80-90% of all ovarian cancers [5] . It is ian cancer were treated at Massachusetts General Hospital. Pa-estimated that 24,000 new cases of ovarian cancer will be tients were identified from the tumor registry and medical records diagnosed in 1994 in the United States and that there will were retrospectively reviewed. Pathological slides were evaluated be over 13,600 deaths [4] . Because of its intra-abdominal for the presence of endometriosis, specifically looking for malig-location and silent course, a late diagnosis with widespread nancy arising in endometriosis. Evidence of endometriosis was carcinomatosis is a common presentation of this disease. 
of malignant transformation of the endometriosis. Between 1975 and 1990, 79 patients with Stage I epithelial ovarian cancer were identified from the Massachusetts General Hospital Cancer Registry and their clinical records were INTRODUCTION reviewed [19] . Tumors of borderline malignancy were excluded from the study. Data, such as presence of endometrioEndometriosis is defined as the presence of endometrial sis, demographic characteristics, medical history, symptoms glands and stroma in ectopic locations. Endometriosis is a at presentation, and diagnostic and therapeutic procedures, benign, but often progressive, disease that has an estimated were recorded for each patient. 10% prevalence in the premenopausal population [1] . Only
Of the 79 patients, pathologic material was available in 71, 2-4% of women with endometriosis are diagnosed in the and all these cases were reviewed by one of the authors (JHE). postmenopausal period [2, 3] .
Five to 69 (mean 31) hematoxylin and eosin-stained sections Ovarian cancer causes more deaths than any other cancer were reviewed per case. Each case was reviewed at least twice over a 3-month period. In cases where biopsy or excision was followed by a definitive staging procedure, the latter slides 1 To whom reprint requests should be addressed at Departamento de were also reviewed. In the 8 cases where archival material was pathology report were reinterpreted in view of typing and grad-endometriosis, 41% were found in association with endometrioid histology, 32% clear cell, 18% mixed (endometrioid ing criteria that are currently applied. Briefly, classification by histologic type was based on the current World Health and/or clear cell), and 9% other subtypes (mucinous and malignant Brenner). Tumors associated with endometriosis Organization classification of ovarian tumors [20] . Tumors were assigned to the mixed epithelial category only when a were grade 1 in 50% of the cases, grade 2 in 32%, and grade 3 in 18%. Twelve of the 22 patients had Stage Ia tumor and second component represented 25% or greater of the sampled tumor tissue. All tumors were reassigned a grade from 1 to 10 had Stage Ic. Evaluation of all the Stage I endometrioid and clear cell ovarian cancers, which presented over the 15-3. Endometrioid adenocarcinomas of the ovary were graded according to criteria recently standardized for their endometrial year period, revealed that 9 of the 23 (39%) endometrioid tumors and 7 of the 17 (41%) clear cell tumors were associcounterpart (primarily on architectural grade) [21] . For the other types of ovarian carcinoma (serous, mucinous, clear cell, malig-ated with endometriosis. In addition, 4 more cases of endometrioid or clear cell lesions associated with endometriosis nant Brenner tumor, and mixed), nuclear grade was considered more important than architecture.
were among the 8 tumors with mixed histologies. Table 1 compares clinical and pathologic characteristics Endometriosis was defined as the presence of glandular epithelium accompanied by endometrioid stroma in a site between patients with and without endometriosis. There were three recurrences (one in the pelvis, one in the upper other than the uterine corpus. The presence of unequivocal endometrioid stroma was considered sufficient when epithe-abdomen, and one in the lungs) and deaths among the 22 women with endometriosis (14%) compared to six (11%) lium was absent or metaplastic (nonendometrioid) in type. The presence of hemorrhagic stroma, or stroma containing recurrences (three in the upper abdomen, one in the spine, one in the pelvis, and one in the lungs) and four (7%) deaths hemosiderin or hemofuscin, was considered helpful only in sites that were clearly separate from the tumor since intratu-among the 57 women without endometriosis. The median time to recurrence for the two groups was 86 { 6 and 91 moral hemorrhage and cyst formation would be expected to result in a fibrous, hemosiderotic cyst wall even in the ab-{ 4 months, respectively (P Å 0.82). The characteristics that were statistically different between the two groups were sence of endometriosis. The presence of histologic transformation from benign to malignant disease was necessary to age and obesity. Patients without endometriosis were older and more likely to be obese. In addition, although not statisticonsider malignant tumor to have arisen from endometriosis.
Staging was done retrospectively by the authors using the cally significant, the women without endometriosis were more likely to be parous (P Å 0.11). FIGO staging system for ovarian cancer [22] after a thorough review of pathology slides and reports as described above.
Among the 22 patients with endometriosis, we were able to demonstrate that the malignancy arose from the endometriosis Fisher's exact test [23] and the Wilcoxon rank sum test [24] were used to compare patients with endometriosis to in 32% of the cases (7 cases). The patients were 27 to 69 (mean, 49) years old at presentation and 3 (43%) were prepatients without endometriosis by demographic, historical, and therapeutic characteristics. Kaplan-Meier curves and menopausal; 2 of the 7 also had benign endometriosis of the contralateral ovary and 2 patients had endometriosis at an extrathe log rank test [25] were used to determine what characteristics were associated with time to disease recurrence and genital site. All 7 patients had tumors of endometrioid or clear cell histology. Six of these seven tumors (86%) were grade 2 time to death. or 3, compared to four (27%) with grade 2 or 3 among those without identifiable premalignant changes (P Å 0.01). In none RESULTS of these cases was there a synchronous endometrial cancer. Four of the seven tumors were Stage Ic and three Stage Ia. During the 15-year time period (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) , there were 79 patients with Stage I ovarian cancer. Endometrioid adeno-One of the 7 women developed a pulmonary recurrence and died of her disease 42 months from diagnosis. carcinoma was the most frequently encountered histological subtype, accounting for 23 of the 79 tumors (29%), followed
The transition from benign endometriosis to malignancy was characterized by cytologic atypia and/or architectural by mucinous 18 (23%), clear cell 17 (22%), serous 10 (13%), mixed 8 (10%), and malignant Brenner 3 (4%). Twenty-nine proliferation. The elements that suggested a premalignant transition differed among the seven cases. In two tumors (37%) were grade 1, 28 (35%) were grade 2, and 22 (28%) were grade 3.
(one endometrioid, one mixed endometrioid/clear cell), a prominent adenofibromatous or adenoacanthofibromatous Endometriosis was found in 22 of the 79 cases (28%). The 22 patients did not include any of the 8 patients where component emerged within areas of endometriosis (Fig. 1) .
In three other tumors (two endometrioid, one clear cell), slides were unavailable. The median age of the 22 patients was 58 years (range 22-83) and 14 (64%) were nulliparous. minor areas of glandular crowding and irregularity resembling endometrial hyperplasia, with at least nuclear atypiTen patients (45%) were premenopausal, 8 (36%) had associated hypertension, and 2 (9%) were obese. cality, were found within endometriotic foci (Fig. 2) . In one of the endometrioid adenocarcinomas in the latter group, Of the 22 patients with Stage I tumors associated with intraluminal papillary tufting of atypical epithelial cells was proposed the following criteria: (a) The presence of both malignant and benign endometrial tissue in the same ovary, focally conspicuous (Fig. 3) . The final two cases were clear (b) the demonstration of cancer arising in the ovarian endocell cystadenocarcinomas in which areas of endometriotic metriosis and not arising from elsewhere, and (c) the finding cyst lining separate from the tumor showed nuclear atypiof tissue resembling endometrial stroma surrounding characcality of glandular and surface epithelial elements (Fig. 4) .
teristic epithelial glands. In 1953, Scott [7] suggested an additional qualification to DISCUSSION complete Sampson's criteria: the demonstration of a transiMalignant transformation of endometriosis is a rare but tion between benign endometriosis and malignant epitherecognized complication of this disease. In 1925, Sampson lium. Other authors [10] [11] [12] [13] [14] have recommended close scru- [6] reported seven cases of ovarian carcinoma that he be-tiny of cellular atypia and/or hyperplasia in ectopic endomelieved could have arisen from foci of endometriosis. In order trial tissue to define lesions that may be preneoplastic.
Over two-thirds of ovarian cancers are diagnosed in adto consider a carcinoma originating in endometriosis, he FIG. 1. Glandular proliferation with squamous differentiation and a fibromatous stroma (adenoacanthofibroma) adjacent to an area of endometriosis; a component with this pattern was seen in two cases (501).
FIG. 2.
Slight glandular crowding and irregularity in an endometriotic area adjacent to an ovarian cancer; atypical nuclei were rounded and vesicular (2501).
vanced stages [4] . Our study is composed of a rare subset of earlier diagnosis of this otherwise silent disease in early stages.
In our series, 43% of women with endometriosis presented patients with Stage I disease. Interestingly, we found a high frequency of coexistent endometriosis within this cohort of 79 with pain which led to an evaluation and diagnosis of an ovarian malignancy. On the contrary, the majority of women with adpatients. An explanation for our findings would be the fact that endometriosis may be symptomatic, which may lead to an vanced ovarian cancer are relatively asymptomatic. The association between endometriosis and clear cell or the endometrioid and 41% of the clear cell ovarian cancers.
In the 7 of the 42 (17%) clear cell and endometrioid tumors endometrioid ovarian cancer is well documented. In general, endometriosis is associated with 30-40% of these histolo-(including two with mixed endometrioid/clear cell histology), a clear transition from benign to atypical to malignancy gies [17, 18] , raising the question of whether endometriosis is a premalignant condition. In our study of patients with was documented.
In our study, strict criteria were used to define an endomeStage I disease, endometriosis was associated with 39% of triotic cyst that was contiguous or intimately associated with who did not receive hormones, after consideration of other confounding factors. Reimnitz et al. [27] reported two cases an ovarian tumor. Intratumoral hemorrhage and cyst formation (artifacts of rupture) and distention of adjacent hemor-of malignancy arising from a focus of endometriosis after surgical castration and unopposed estrogen replacement therrhagic follicle cysts or atypical cortical inclusion cysts may all produce an appearance that mimics an endometriotic cyst. apy. The authors of this last study recommended the use of progestins in replacement therapy to reduce the risk of The use of strict criteria particularly applies to cystic endometrioid adenocarcinomas, which by their nature have neo-malignancy arising in endometriosis. Our study does not specifically address this issue because none of our patients plastic epithelium of an endometrial type and a component that may resemble endometrial stroma. In addition, a transi-with ovarian cancer and associated endometriosis were taking unopposed estrogen. Based on the study by Reimnitz tion from benign endometriosis to malignancy with the presence of cytologic atypia and/or architectural proliferation et al.
[27], we feel that if estrogen replacement therapy is prescribed in this group of patients, progestins should also had to be present in order to consider an endometriotic origin of the ovarian carcinoma. be given. Endometriosis was frequently encountered among patients In our study, seven patients were found to have a malignancy arising from endometriosis using these strict criteria. with Stage I epithelial ovarian cancer of endometrioid and clear cell histologies. A variety of lesions that might have Fifteen other women were found to have cancer and endometriosis without identifiable evidence of premalignant premalignant potential were found when evaluating the pathologic slides in some of these patients. Our study and changes. However, the precancerous stage may not have been histologically present because it may have already been others suggest that some patients with endometriosis may be at risk of developing ovarian malignancies. Further studies destroyed by the tumor. These findings suggest that ovarian endometriosis may act as a precursor to certain types of attempting to identify those patients with endometriosis that are at greatest risk of developing a malignancy are warranted. ovarian carcinomas, specifically endometrioid and clear cell subtypes. A related issue is how to identify those endometri-Excision of endometriotic implants and endometriomas with careful histologic evaluation to characterize cytologic atypia otic lesions that are potentially premalignant. Most other investigators have focused on Sampson's [6] criteria with or architectural proliferation may help in identifying which lesions are truly premalignant. Scott's [7] modification. Those criteria are only pertinent to evaluate if a malignancy arose from endometriosis. However, our criteria of cytologic atypia and/or architectural pro
